guest ::
| Home > Publications Database > Targeting aberrant dendritic integration to treat cognitive comorbidities of epilepsy. > print |
| Home > Publications Database > Targeting aberrant dendritic integration to treat cognitive comorbidities of epilepsy. > print |
| 001 | 258241 | ||
| 005 | 20240611120549.0 | ||
| 024 | 7 | _ | |a 10.1093/brain/awac455 |2 doi |
| 024 | 7 | _ | |a pmid:36448426 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC10232249 |2 pmc |
| 024 | 7 | _ | |a 0006-8950 |2 ISSN |
| 024 | 7 | _ | |a 1460-2156 |2 ISSN |
| 024 | 7 | _ | |a altmetric:139626830 |2 altmetric |
| 037 | _ | _ | |a DZNE-2023-00587 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Masala, Nicola |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a Targeting aberrant dendritic integration to treat cognitive comorbidities of epilepsy. |
| 260 | _ | _ | |a Oxford |c 2023 |b Oxford Univ. Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1718023396_5321 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Memory deficits are a debilitating symptom of epilepsy, but little is known about mechanisms underlying cognitive deficits. Here, we describe a Na+ channel-dependent mechanism underlying altered hippocampal dendritic integration, degraded place coding and deficits in spatial memory. Two-photon glutamate uncaging experiments revealed a marked increase in the fraction of hippocampal first-order CA1 pyramidal cell dendrites capable of generating dendritic spikes in the kainate model of chronic epilepsy. Moreover, in epileptic mice dendritic spikes were generated with lower input synchrony, and with a lower threshold. The Nav1.3/1.1 selective Na+ channel blocker ICA-121431 reversed dendritic hyperexcitability in epileptic mice, while the Nav1.2/1.6 preferring anticonvulsant S-Lic did not. We used in vivo two-photon imaging to determine if aberrant dendritic excitability is associated with altered place-related firing of CA1 neurons. We show that ICA-121431 improves degraded hippocampal spatial representations in epileptic mice. Finally, behavioural experiments show that reversing aberrant dendritic excitability with ICA-121431 reverses hippocampal memory deficits. Thus, a dendritic channelopathy may underlie cognitive deficits in epilepsy and targeting it pharmacologically may constitute a new avenue to enhance cognition. |
| 536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 0 |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a calcium imaging |2 Other |
| 650 | _ | 7 | |a cognitive comorbidities |2 Other |
| 650 | _ | 7 | |a dendritic integration |2 Other |
| 650 | _ | 7 | |a dendritic spike |2 Other |
| 650 | _ | 7 | |a epilepsy |2 Other |
| 650 | _ | 7 | |a ICA-121431 |2 NLM Chemicals |
| 650 | _ | 7 | |a Acetamides |2 NLM Chemicals |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Dendrites: physiology |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: physiology |2 MeSH |
| 650 | _ | 2 | |a Acetamides: metabolism |2 MeSH |
| 650 | _ | 2 | |a Pyramidal Cells: metabolism |2 MeSH |
| 650 | _ | 2 | |a Epilepsy: metabolism |2 MeSH |
| 650 | _ | 2 | |a Action Potentials: physiology |2 MeSH |
| 700 | 1 | _ | |a Pofahl, Martin |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Haubrich, André N |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Sameen Islam, Khondker Ushna |b 3 |
| 700 | 1 | _ | |a Nikbakht, Negar |b 4 |
| 700 | 1 | _ | |a Pasdarnavab, Maryam |b 5 |
| 700 | 1 | _ | |a Bohmbach, Kirsten |b 6 |
| 700 | 1 | _ | |a Araki, Kunihiko |b 7 |
| 700 | 1 | _ | |a Kamali, Fateme |b 8 |
| 700 | 1 | _ | |a Henneberger, Christian |0 P:(DE-2719)2811625 |b 9 |u dzne |
| 700 | 1 | _ | |a Golcuk, Kurtulus |b 10 |
| 700 | 1 | _ | |a Ewell, Laura A |b 11 |
| 700 | 1 | _ | |a Blaess, Sandra |b 12 |
| 700 | 1 | _ | |a Kelly, Tony |b 13 |
| 700 | 1 | _ | |a Beck, Heinz |0 P:(DE-2719)2000044 |b 14 |e Last author |u dzne |
| 773 | _ | _ | |a 10.1093/brain/awac455 |g Vol. 146, no. 6, p. 2399 - 2417 |0 PERI:(DE-600)1474117-9 |n 6 |p 2399 - 2417 |t Brain |v 146 |y 2023 |x 0006-8950 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/258241/files/DZNE-2023-00587%20SUP.pdf |
| 856 | 4 | _ | |u https://pub.dzne.de/record/258241/files/DZNE-2023-00587%20SUP.pdf?subformat=pdfa |x pdfa |
| 856 | 4 | _ | |u https://pub.dzne.de/record/258241/files/DZNE-2023-00587.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://pub.dzne.de/record/258241/files/DZNE-2023-00587.pdf?subformat=pdfa |x pdfa |y OpenAccess |
| 909 | C | O | |o oai:pub.dzne.de:258241 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2811625 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2000044 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 1 |
| 914 | 1 | _ | |y 2023 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2022-11-09 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2022-11-09 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2023-10-21 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-10-21 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BRAIN : 2022 |d 2023-10-21 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-10-21 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-10-21 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b BRAIN : 2022 |d 2023-10-21 |
| 920 | 1 | _ | |0 I:(DE-2719)1013029 |k AG Henneberger |l Synaptic and Glial Plasticity |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1013029 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|